A2E selectively induces COX-2 in ARPE-19 and human neural cells

Current Eye Research

Volumn 31, Issue 3, 2006, Pages 259-263

  Lukiw, Walter J ^a   Mukherjee, Pranab K ^a   Cui, Jian Guo ^a   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A2E; ARPE 19; COX 1; COX 2; COX 3; Cyclooxygenase; Human neural (HN) cells

Indexed keywords

2 [2,6 DIMETHYL 8 (2,6,6 TRIMETHYL 1 CYCLOHEXEN 1 YL)OCTATETRAENYL] 1 (2 HYDROXYETHYL) 4 [4 METHYL 6 (2,6,6 TRIMETHYL 1 CYCLOHEXEN 1 YL)HEXATRIENYL]PYRIDINIUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; LIPOFUSCIN; MESSENGER RNA; RETINOID; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; EXPOSURE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOASSAY; INFLAMMATION; NERVE CELL; NORTHERN BLOTTING; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RNA ISOLATION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CYCLOOXYGENASE 2; GENE EXPRESSION; HUMANS; NEUROGLIA; PIGMENT EPITHELIUM OF EYE; PYRIDINIUM COMPOUNDS; RETINOIDS; RNA;

EID: 33644895745     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680600556974     Document Type: Article

References (18)

1. Simmons DL, Botting RM, Hla T. Cydooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004;56:387-437.
2. Garavito RM, Mulichak AM. The structure of mammalian cyclooxygenases. Annu Rev Biophys Biomol Struct. 2003;32:183-206.
3. Katori M, Majima M. Cyclooxygenase-2: Its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res. 2000;49:367-392.
4. Cui JG, Koroda H, Chandrasekharan NV, et al. Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells. Neurochem Res. 2004; 29:1731-1737.
5. Kitamura Y, Shimohama S, Koike H, et al. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem Biophys Res Commun. 1999;254:582-586.
6. Kiefer W, Dannhardt G. Novel insights and therapeutical applications in the field of inhibitors of COX-2. Curr Med Chem. 2004;11:3147-3161.
7. Newton R, Kuitert LM, Bergmann M, et al. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun. 1997;237:28-32.
8. Bazan NG, Lukiw WJ. Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1 beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem. 2002;277:30359-30367.
9. Lukiw WJ, Ottlecz A, Lambrou G, et al. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci. 2003;44:4163-4170.
10. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res. 2005;80:595-606.
11. Sparrow JR, Fishkin N, Zhou J, et al. A2E, a by-product of the visual cycle. Vision Res. 2003;43:2983-2990.
12. Zhou J, Cai B, Jang YP, et al. Mechanisms for the induction of HNE-MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res. 2005;80: 567-580.
13. Gaillard ER, Avalle LB, Keller LM, et al. A mechanistic study of the photooxidation of A2E, a component of human retinal lipofuscin. Exp Eye Res. 2004;79:313-319.
14. Castro MR, Lutz D, Edelman JL. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization. Exp Eye Res. 2004;79:275-285.
15. Pogue Al, Lukiw WJ. Angiogenic signaling in Alzheimer's disease. Neuroreport. 2004;15:1507-1510.
16. Wang W, Bergh A, Damber JE. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res. 2005;11:3250-3256.
17. Huang SP, Wu MS, Shun CT, et al. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci. 2005;12:229-241.
18. Wilkinson-Berka JL. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr Pharm Des. 2004;10: 3331-3348.